Alpha Tau Medical Completes Enrollment For U.S. Skin Cancer Study, Advancing Toward FDA Approval For Alpha DaRT Recurrent Cutaneous Squamous Cell Carcinoma Treatment
Alpha Tau Medical Ltd
Alpha Tau Medical Ltd DRTS | 0.00 |
Alpha Tau Medical Completes Enrollment For U.S. Skin Cancer Study, Advancing Toward FDA Approval For Alpha DaRT Recurrent Cutaneous Squamous Cell Carcinoma Treatment